GENERAL ORDER 19-0004: RESETTING OF DEADLINES IN CIVIL MATTERS INVOLVING THE UNITED STATES AS A PARTY. Honorable Ruben Castillo no longer assigned to the case. Case reassigned to the Honorable Charles R. and It is further ordered that Magistrate Judge Valdez will be the designated magistrate judge in 15 C 6204, Doe et al., v. Snap Diagnostics, LLC et al., to the Hon. Maria Valdez therefore, It is hereby ordered that the Clerk is directed to reassign 15 C 6204, Doe et al., v. and the designated magistrate judge is the Hon. Snap Diagnostics LLC et al., was reassigned to the Hon. Snap Diagnostics, LLC et al., are granted and the cases shall be consolidated for all purposes and should be presided over by a single district judge and a designated magistrate judge for these cases and It further appearing that 14 C 3988, Piacentile et al., v. Snap Diagnostics LLC et al., and 15 C 6204, Doe et al., v. ISO 13485 specifies requirements for a quality management system where an organization needs to demonstrate its ability to provide medical devices and related services that consistently meet customer requirements and regulatory requirements applicable to medical devices and related services.EXECUTIVE COMMITTEE ORDER: It appearing that, for reasons of judicial efficiency, the motions to consolidate filed in 14 C 3988, Piacentile et al., v. SNAP Diagnostics is also ISO 13485 Certified. By demonstrating compliance with The Joint Commission‘s national standards for health care quality and safety, SNAP Diagnostics has earned the Joint Commission’s Gold Seal of Approval™. SNAP Diagnostics is an approved Independent Diagnostic Testing Facility (IDTF) by Medicare. SNAP's commitment to provide innovative, convenient, cost-effective solutions for respiratory disorders uniquely positions us in the largely untapped sleep disorders market. The SNAP Test has been prescribed by thousands of medical professionals throughout the United States and administered in the privacy of the patient’s home. The SNAP Test uses a proprietary digital sound recording and blood oxygen recording and analysis system to help physicians choose the best course of treatment for patients. We perform more diagnostic tests in a month than the average traditional sleep laboratory performs in a year. We are dedicated to developing, manufacturing and marketing products to aid in the diagnosis, analysis and management of respiratory disorders with an initial focus on obstructive sleep apnea and snoring outside the traditional hospital setting.Īfter receiving FDA clearance of the SNAP Sleep Apnea and Snoring Analysis System in 1995, SNAP began marketing in 1996 and today is considered the leader in the development of technology for the detection of sleep apnea and the analysis of snoring patterns. Recognizing the need to improve diagnosis and treatment of sleep-related breathing disorders, SNAP Diagnostics was founded in March, 1994. Sleep apnea is under-diagnosed because the standard method of diagnosis requires an overnight hospital stay which can be costly, inconvenient, and uncomfortable for patients. In addition, approximately 5-10% of the adult population suffers from sleep apnea. Medical experts project that over 50 million American adults snore habitually. Public and professional awareness of the prevalence and potential serious consequences of snoring and sleep apnea is growing rapidly. SNAP Diagnostics is a private medical device and service company dedicated to improving the diagnosis of sleep-related breathing disorders.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |